Significance of lymphadenopathy in IgG4-related sclerosing disease and sarcoidosis.

journal.publications.chestnet.org patients). Similarly, determining the incidence of HIT in patients exposed to therapeutic treatment with heparin was supported by a paper reporting a retrospective study assessing the incidence of secondary thrombocytopenia recorded in the discharge boards of patients who were referred for a short stay in nonfederal US hospitals with a diagnostic code for thromboembolism and related outcomes. Beside the fact that the meta-analysis reported in this paper did not focus on HIT, it lacked most quality parameters. 3 , 4 Although high-quality evidence from randomized controlled trials regarding the incidence of HIT in postoperative patients has, to date, been sparse, 5 I believe the previous examples indicate that there is a need to explore this issue more carefully in the ACCP Guideline to prevent this dangerous, adverse drug reaction.